Skip to main content

Table 1 Demographic characteristics and health metrics

From: Health Disparities among adults cared for at an urban cystic fibrosis program

  Non-Hispanic Caucasian (n = 223) Black/LatinX (n = 39) p
Female (n, %) 125 (56.1%) 17 (43.6%) 0.149
Mean current age *(standard deviation SD) 35.9 (13.3)) 32.1 (9.3) 0.087
Mean age at diagnosis, years * 9.56 (15.9) 11.59 (15.8) 0.46
Mean sweat chloride * 92.9 (4.5) 90.4 (1.7) 0.87
Mean FEV1 L * 3.01 (7.08) 2.19L (1.07) 0.47
Mean FEV1 (%) * 70.6 (22.5) 59.5 (27.92) 0.010
Mean FVC L * 3.68 (1.13) 3.15 (1.19) 0.008
Mean FVC (% predicted) * 84.17 (18.46) 73.00 (24.69) 0.002
FEV1/FVC * 0.77 (1.34) 0.67 (0.15) 0.65
Mean BMI * 23.02 (4.09) 22.44 (4.20) 0.446
Diabetes (n, %) 56 (25.1) 14 (35.9) 0.160
Pseudomonas aeruginosa (n, %) 138 (62) 25 (64) 0.67
Mean no. encounters 4.64 (0.17) 4.4 (0.38) 0.96
Mean no. Intravenous antibiotic (IV) courses * 0.68 (0.07) 0.74 (0.22) 0.67
Hospitalizations * 0.27 (0.05) 0.86 (0.15) 0.14
Days treated with IV antibiotics * 11.5 (1.3) 12.23 (3.9) 0.92
Median income * 102,494 (36,060) 68,485 (33,159) < 0.001
Medicaid (n, %) 18 (8.7%) 17 (45.9%) < 0.001
Medicaid/Medicare (n, %) 39 (17.5%) 19 (48.7%) < 0.001
Treated with modulators (n, %) in 2019 116 (52%) 13 (38%) 0.78
Eligible for elexacaftor/tezacaftor/ivacaftor 170 (76%) 24 (62%) 0.87
  1. *Standard deviation